Antibe Therapeutics Inc.

ATBPF · OTC
Analyze with AI
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Assets
Cash & Equivalents$6,755$34,807$71,973$6,182
Short-Term Investments$32,137$20,000$25$25
Receivables$1,615$1,121$1,061$1,694
Inventory$0$36$2,157$3,424
Other Curr. Assets$1,039$5,436$3,887$182
Total Curr. Assets$41,546$61,364$79,103$11,507
Property Plant & Equip (Net)$0$0$309$303
Goodwill$0$0$0$0
Intangibles$26,352$26,352$869$1,771
Long-Term Investments$0$159$157$0
Tax Assets$0$0-$157$0
Other NC Assets$2,663$1,283$1,460$257
Total NC Assets$29,015$27,794$2,638$2,331
Other Assets$0$0$0$0
Total Assets$70,561$89,158$81,741$13,838
Liabilities
Payables$3$2,251$2,330$3,978
Short-Term Debt$0$0$133$2,333
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0-$3,978
Other Curr. Liab.$2,761$1,878$1,278$1,284
Total Curr. Liab.$2,764$4,694$3,741$7,595
LT Debt$0$0$105$65
Deferred Rev, NC$27,631$27,631$27,631$2,399
Deferred Tax Liab, NC$0$0-$28-$2
Other NC Liab.$0$0$0$0
Total NC Liab.$27,631$27,631$27,736$2,464
Other Liabilities$0$0$0$0
Cap. Leases$0$0$238$180
Total Liabilities$30,395$32,325$31,477$10,059
Equity
Pref Stock$0$0$0$0
Common Stock$141,489$139,547$111,574$49,666
Retained Earnings-$130,491-$111,016-$85,956-$59,673
AOCI$0$10,264$10,353$18
Other Equity$29,168$18,038$14,293$13,768
Total Equity$40,166$56,833$50,264$3,779
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$70,561$89,158$81,741$13,838
Net Debt-$6,755-$34,807-$71,735-$3,784